US Senate to vote this week on legislation seeking to codify abortion rights into law; hospitals aiming to raise treatment prices in response to increasing nurse salaries; shortage of infant formula worsening nationwide.
Senate Majority Leader Chuck Schumer said yesterday that the US Senate will vote Wednesday, May 11, on legislation seeking to codify abortion rights into law. Reuters is reporting that the move is in reponse to the leaked draft majority opinion written by Justice Samuel Alito indicating the Supreme Court will likely overturn the landmark Roe v Wade decision. A poll by CBS News and YouGov showed that a majority of Americans favored making abortion legal, including 76% of Democrats and 52% of Republicans.
The Wall Street Journal is reporting that some hospitals aim to raise prices by 7.5% to 15% in response to increasing nurse salaries. With demand for nurses having risen substantially amid the pandemic, hospitals are asking for more than the 4% to 6% price increases typically sought, which would result in higher premiums for employers and their respective workforce. Insurer and employer groups were noted to have rejected the requests, citing that the most expensive hospitals can absorb the higher labor costs without raising their rates. Hospitals currently account for a large proportion of US health spending per year, with an estimated $1 trillion in costs.
USA Today is reporting that the infant formula shortage is worsening nationwide as nearly 40% of popular brands were sold out during the week of April 24, compared with 31% in the 2 weeks prior. The shortage was exacerbated by the voluntary recall of popular Abbott baby formulas, including select batches of Similac, Alimentum, and EleCare, in February 2022. Severe supply shortages higher than 50% were cited in 6 states, Tennessee, Texas, Missouri, Iowa, South Dakota, and North Dakota, with San Antonio reporting the highest out-of-supply rate for a metro area across the United States.
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Study Highlights Disparities in Access to In-Network Mental Health Care vs Medical Care
April 17th 2024While health plans often employ reimbursement rates as a tool to incentivize provider participation within their networks, study results showed reimbursement rates for office visits with medical/surgical clinicians were on average 22% higher than behavioral health clinicians.
Read More